Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $61.74 ($1.2M) on 2024-08-21, disclosed to the SEC on 2024-08-21.
Scheduled sale ($1.2M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.06 | 10,000 | $611K | 49.7% |
| 2 | $61.74 | 9,900 | $611K | 49.8% |
| 3 | $62.34 | 100 | $6K | 0.5% |
| Total | $61.40 avg | 20,000 | $1.2M | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |
| HALO | SELL | 2024-06-20 | $494K | — | Filing → |